80年代土耳其译制电影,80年代外国电影|80年代外国电影有哪些_80年代外国经典电影在线播放地址是多少？

[1]許雪峰,陳彥,趙潔馨,等.幽門螺桿菌感染與非酒精性脂肪性肝病的關(guān)系探討[J].福建醫(yī)藥雜志,2022,44(04):8-11.
　XU Xuefeng,CHEN Yan,ZHAO Jiexin,et al.Relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease[J].FUJIAN MEDICAL JOURNAL,2022,44(04):8-11.
點擊復(fù)制

幽門螺桿菌感染與非酒精性脂肪性肝病的關(guān)系探討()
分享到：

《福建醫(yī)藥雜志》[ISSN:1002-2600/CN:35-1071/R]

卷:
44
期數(shù):
2022年04期
頁碼:
8-11
欄目:
臨床研究
出版日期:
2022-08-15

文章信息/Info

Title:
Relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease
文章編號:
1002-2600(2022)04-0008-04
作者:
許雪峰; 陳彥1; 趙潔馨2; 鄭承超3; 林雄峰4; 吳芳梅; 黃艷芳; 黃雪梅; 鄭銘2; 5
福建醫(yī)科大學(xué)省立臨床醫(yī)學(xué)院 福建省立醫(yī)院消化內(nèi)科(福州 350001)
Author(s):
XU Xuefeng;  CHEN Yan;  ZHAO Jiexin;  ZHEN Chenchao;  LIN Xiongfeng;  WU Fangmei;  HUANG Yanfang;  HUANG Xuemei;  ZHENG Ming
Department of Medical Gastroenterology, Fujian Provincial Hospital, Fuzhou, Fujian 350001, China
關(guān)鍵詞:
幽門螺桿菌; 非酒精性脂肪性肝病; 糖尿病; 低密度脂蛋白膽固醇
Keywords:
helicobacter pylori;  nonalcoholic fatty liver disease;  diabetes mellitus;  low-density lipoprotein cholesterol
分類號:
R575.5
文獻標(biāo)志碼:
A
摘要:
目的 探討幽門螺桿菌(Hp)感染與非酒精性脂肪性肝病(NAFLD)的關(guān)系。方法 收集我院行快速尿素酶試驗同時行腹部超聲檢查的住院患者共920例,根據(jù)有無合并NAFLD,分為NAFLD組及對照組,通過二元logistic回歸分析Hp感染與NAFLD的關(guān)系。結(jié)果 總研究對象中,NAFLD組(387例)Hp陽性者為98例,對照組(533例)Hp陽性者為119例,NAFLD組Hp感染率較對照組高(25.3% vs 22.3%),但兩組Hp感染率差異無統(tǒng)計學(xué)意義(P=0.291); 但在DM人群中,NAFLD組(94例)Hp陽性者27例,對照組(61例)Hp陽性者9例,NAFLD組較對照組Hp感染率高(28.7% vs 14.8%),且兩組差異有統(tǒng)計學(xué)意義(χ2=4.048,P=0.048)。在調(diào)整除TC、LDL-C、HDL-C等3個血脂指標(biāo)之外的其他因素后,二元logistic回歸分析仍顯示兩組Hp感染率差異有統(tǒng)計學(xué)意義(P=0.030)。而在調(diào)整上述3個血脂指標(biāo)后,兩組Hp感染率差異無統(tǒng)計學(xué)意義(P=0.215)。另該3個血脂指標(biāo)中只發(fā)現(xiàn)LDL-C與NAFLD存在關(guān)聯(lián)(P=0.000)。結(jié)論 DM患者Hp感染與NAFLD存在關(guān)聯(lián),且兩者之間的關(guān)聯(lián)可能是通過LDL-C介導(dǎo)。
Abstract:
Objective To investigate the relationship between Helicobacter pylori(Hp)infection and Nonalcoholic fatty liver disease(NAFLD). Methods A total of 920 inpatients who underwent rapid urease test and abdominal ultrasonography were collected.According to the presence or absence of NAFLD, they were divided into NAFLD group and control group.Logistic regression analysis was used to study the relationship between Hp infection and NAFLD.Results Among the total study subjects, 98 cases were Hp positive in the NAFLD group(387 cases), and 119 cases were Hp positive in the control group(533 cases).There was no significant difference in the Hp infection rate between the two groups(P=0.291); but in the DM population, 27 cases were Hp positive in the NAFLD group(94 cases), and 9 cases were Hp positive in the control group(61 cases).The infection rate of H.pylori in the NAFLD group was higher than that in the control group(28.7% vs 14.8%), and the difference between the two groups was statistically significant(χ2=4.048,P=0.048).After adjusting for other factors except cholesterol(TC), low-density lipoprotein cholesterol(LDL-C), high-density lipoprotein cholesterol(HDL-C), the Hp infection rate between the two groups was statistically significant(P=0.030).After adjusting the above three blood lipid indexes, there was no statistical significance in the difference of Hp infection rate between the two groups(P=0.215).In the other three blood lipid indexes, only LDL-C and NAFLD were found to be correlated(P=0.000). Conclusion There is an association between Hp infection and NAFLD in DM patients, and the association between the two may be mediated by LDL-C.

參考文獻/References:

[1] Wessler S, Krisch L M, Elmer D P, et al.From inflammation to gastric cancer- the importance of Hedgehog/GLI signaling in Helicobacter pylori-induced chronic inflammatory and neoplastic diseases[J].Cell Commun Signal, 2017,15(1):15.
[2] 中華醫(yī)學(xué)會消化病學(xué)分會幽門螺桿菌和消化性潰瘍學(xué)組, 全國幽門螺桿菌研究協(xié)作組, 劉文忠, 等.第五次全國幽門螺桿菌感染處理共識報告[J].中華消化雜志, 2017,37(6):364-378.
[3] Tsay F W, Hsu P I.H.pylori infection and extra-gastroduodenal diseases[J].J Biomed Sci,2018,25(1):65.
[4] Polyzos S A, Papaefthymiou, Doulberis M, et al.Helicobacter pylori infection and diabetes mellitus[J].Diabetes Metab Syndr, 2021,15(3):845-846.
[5] Wang F, Fu Y, Lv Z,et al.Association of Helicobacter pylori infection with diabetic complications: a meta-analysis[J].Endocr Res, 2014,39(1):7-12.
[6] 非酒精性脂肪性肝病防治指南(2018年更新版)[J].實用肝臟病雜志,2018,21(2):177-186.
[7] Younossi Z M, Koenig A B, Abdelatif D, et al.Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes[J].Hepatology, 2016, 64(1):73-84.
[8] Maharshi V, Gupta P, Kumar V L, et al.Effect of Helicobacter pylori-eradication therapy on hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomized-controlled pilot study[J].Gastroenterol Report2019, 8(2):104-110.
[9] Nagy P,Tahansson S,Molloy-Bland M,et al.Systematic review of time trends in the prevalence of Helicobacter pylori infection in China and the USA[J].Gut Pathog, 2016, 8:8.
[10] Upala S, Sanguankeo A.Association between Helicobacter pylori infection and insulin resistance: a meta-analysis[J].Diabetes Metab Res Rev, 2016, 32(2):176-177.
[11] Siregar G A, Halim S, Sitepu V R,et al.Serum TNF-a, IL-8, VEGF levels in Helicobacter pylori infection and their association with degree of gastritis[J].Acta Med Indones, 2015, 47(2):120-126.
[12] Akash M S H, Rehman K, Liaqat A,et al.Tumor Necrosis Factor-Alpha: Role in Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes Mellitus[J].J Cell Biochem, 2018, 119(1):105-110.

相似文獻/References:

[1]方劍鋒.三聯(lián)療法兩種療程治療老年幽門螺桿菌陽性消化性潰瘍患者療效分析[J].福建醫(yī)藥雜志,2017,39(4):122.
[2]彭如潔 曾慶新.幽門螺桿菌感染及胃黏膜病理改變對血清ghrelin水平的影響[J].福建醫(yī)藥雜志,2017,39(5):37.
[3]陳煜杉,黃雪平,林志輝.幽門螺桿菌對3種常用抗生素的體外耐藥情況分析[J].福建醫(yī)藥雜志,2022,44(01):14.
　CHEN Yushan,HUANG Xueping,LIN Zhihui.In vitro resistance of helicobacter pylori to 3 commonly used antibiotics[J].FUJIAN MEDICAL JOURNAL,2022,44(04):14.
[4]趙潔馨,陳彥,許雪峰,等.非酒精性脂肪性肝病與急性胰腺炎嚴重程度的相關(guān)性分析[J].福建醫(yī)藥雜志,2023,45(01):15.
　ZHAO Jiexin,CHEN Yan,XU Xuefeng,et al.Correlation between nonalcoholic fatty liver disease and the severity of acute pancreatitis[J].FUJIAN MEDICAL JOURNAL,2023,45(04):15.

備注/Memo

備注/Memo:
基金項目:福建省科技計劃社會發(fā)展引導(dǎo)性(重點)項目(2019Y0056)
1 福建省立金山醫(yī)院內(nèi)科; 2 干部特診科; 3 福建省老年醫(yī)院消化內(nèi)科; 4 福建省立金山醫(yī)院內(nèi)鏡中心; 5 通信作者,Email:[email protected]
更新日期/Last Update: 2022-08-15